M. Drouet et al., HLA AND SUSCEPTIBILITY TO 2 DISTINCT TYPES OF DRUG-INDUCED CUTANEOUS REACTIONS, EJD. European journal of dermatology, 7(5), 1997, pp. 329-332
The purpose of this work was to investigate HLA predisposition in two
types of cutaneous drug reactions, which involve type IV hypersensitiv
ity: maculopapular papular rash, a common clinical form, and acute gen
eralized exanthematous pustulosis, a rare form. The frequency of the D
RB11301 DQB1*0603 haplotype was increased in the maculopapular rash (
17.5% versus 6.4% in the control, relative risk (RR) = 3.7), whereas t
he HLA-B51(5) phenotype was increased in acute generalized exanthemato
us pustulosis (46.7% versus 14.6%, RR = 5.1); but the differences were
not significant after correction for the p value. The culprit drugs w
ere stratified in three categories: pristinamycin, other antibiotics a
nd non-antibiotics: no HLA association could be established with the c
ulprit drugs. DRB101 allele frequency was decreased in both types of
cutaneous drug reactions, suggesting that this allele could confer a p
rotective effect to the both types. Although these results suggest a H
LA predisposition to cutaneous drug reaction, they need to be validate
d on a larger sample of patients.